Synageva BioPharma To Present At The Morgan Stanley Global Healthcare Conference

LEXINGTON, Mass., Sept. 2, 2014 /PRNewswire/ -- Synageva BioPharma Corp. ("Synageva") (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today announced that Sanj K. Patel, President and Chief Executive Officer of Synageva, will present at the Morgan Stanley Global Healthcare Conference in New York City on Tuesday, September 9, 2014, at 8:00 a.m. EDT. The presentation will be webcast live and may be accessed from the "Webcasts & Presentations" section of the Investor Relations tab on the home page of Synageva's website at www.synageva.com.

Photo - http://photos.prnewswire.com/prnh/20140522/90728

Synageva routinely posts information that may be important to investors in the "Investor Relations" section of the company's website at www.synageva.com. Synageva encourages investors and potential investors to consult this website regularly for important information about the company.

Further information regarding Synageva BioPharma Corp. is available at www.synageva.com.

SOURCE Synageva BioPharma Corp.